NCT02775877

Letrozole and Sequential Clomiphene to Improve the Outcome of Embryo Transfer

Letrozole and Sequential Clomiphene to Improve the Outcome of Embryo Transfer in Polycystic Ovary Syndrome (PCOS) Patients

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Navy General Hospital, Beijing · Academic / Other
• Sex: Female
• Age: 20 Years – 38 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to study the effects of letrozole and sequential clomiphene in ovulation and pregnancy in PCOS patients.

Detailed description

To evaluate the efficacy of letrozole and clomiphene in PCOS patients is important,especially in resistent PCOS patients. Although most medications prove the effectiveness of letrozole and clomiphene,the subjects of letrozole and sequential clomiphene in PCOS patients are rarely.The trial may provide further basis for this medication in PCOS patients in ovulation. If the medication demonstrates efficacy, the method would help the patients with PCOS to deal with the problem of infertility.

Conditions

• Female Infertility Due to Nonimplantation of Ovum

Interventions

Type	Name	Description
DRUG	Letrozole
DRUG	clomiphene
DRUG	HMG

Timeline

• Start date: 2016-05-01
• Primary completion: 2019-06-01
• Completion: 2020-01-01
• First posted: 2016-05-18
• Last updated: 2017-06-23

Locations

1 site across 1 country: China